- Home
- CRVS vs VVR Comparison
CRVS vs VVR Comparison
Compare CRVS & VVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- VVR
- Stock Information
- Founded
- CRVS 2014
- VVR 1998
- Country
- CRVS United States
- VVR United States
- Employees
- CRVS N/A
- VVR N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- VVR Trusts Except Educational Religious and Charitable
- Sector
- CRVS Health Care
- VVR Finance
- Exchange
- CRVS Nasdaq
- VVR Nasdaq
- Market Cap
- CRVS 516.0M
- VVR 588.8M
- IPO Year
- CRVS 2016
- VVR N/A
- Fundamental
- Price
- CRVS $4.99
- VVR $3.85
- Analyst Decision
- CRVS Buy
- VVR
- Analyst Count
- CRVS 4
- VVR 0
- Target Price
- CRVS $12.83
- VVR N/A
- AVG Volume (30 Days)
- CRVS 1.6M
- VVR 692.2K
- Earning Date
- CRVS 11-12-2024
- VVR 01-01-0001
- Dividend Yield
- CRVS N/A
- VVR 11.38%
- EPS Growth
- CRVS N/A
- VVR N/A
- EPS
- CRVS N/A
- VVR N/A
- Revenue
- CRVS N/A
- VVR N/A
- Revenue This Year
- CRVS N/A
- VVR N/A
- Revenue Next Year
- CRVS N/A
- VVR N/A
- P/E Ratio
- CRVS N/A
- VVR N/A
- Revenue Growth
- CRVS N/A
- VVR N/A
- 52 Week Low
- CRVS $1.30
- VVR $3.55
- 52 Week High
- CRVS $10.00
- VVR $4.38
- Technical
- Relative Strength Index (RSI)
- CRVS 28.00
- VVR 35.72
- Support Level
- CRVS $3.77
- VVR $4.01
- Resistance Level
- CRVS $7.44
- VVR $4.07
- Average True Range (ATR)
- CRVS 0.60
- VVR 0.05
- MACD
- CRVS -0.41
- VVR -0.02
- Stochastic Oscillator
- CRVS 25.85
- VVR 13.46
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About VVR Invesco Senior Income Trust (DE)
Invesco Senior Income Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide a high level of current income, consistent with the preservation of capital. The company invests in a portfolio of interests in floating or variable senior loans to corporations, partnerships, and other entities which operate in a variety of industries and geographic regions.